(redirected from Small lymphocytic lymphoma)
Also found in: Dictionary, Thesaurus, Medical, Acronyms.


a cancer of the tissue of the lymphatic systemlymphatic system
, network of vessels carrying lymph, or tissue-cleansing fluid, from the tissues into the veins of the circulatory system. The lymphatic system functions along with the circulatory system in absorbing nutrients from the small intestines.
..... Click the link for more information.
. There are two categories of lymphomas. One type is termed Hodgkin's diseaseHodgkin's disease,
a type of cancer of the lymphatic system. First identified in 1832 in England by Thomas Hodgkin, it is a type of malignant lymphoma. Incidence peaks in young adults and the elderly.
..... Click the link for more information.
, the other, non-Hodgkin's lymphoma (see lymphoma, non-Hodgkin'slymphoma, non-Hodgkin's,
any cancer of the lymphoid tissue (see lymphatic system) in which the Reed-Sternberg cells characteristic of Hodgkin's disease (the other category of lymphoma) are not present.
..... Click the link for more information.
). See also neoplasmneoplasm
or tumor,
tissue composed of cells that grow in an abnormal way. Normal tissue is growth-limited, i.e., cell reproduction is equal to cell death. Feedback controls limit cell division after a certain number of cells have developed, allowing for tissue repair
..... Click the link for more information.


Any neoplasm, usually malignant, of the lymphoid tissues.
References in periodicals archive ?
Use of CD23 (BU38) on paraffin sections in the diagnosis of small lymphocytic lymphoma and mantle cell lymphoma.
In reviewing the case of paraimmunoblastic variant of small lymphocytic lymphoma with a bcl-1 translocation, it was not well-characterized immunophenotypically; thus, a large cell variant of MCL (prolymphocytoid type) cannot be excluded entirely.
Flow cytometric and immunohistochemical analysis of small lymphocytic lymphoma, mantle cell lymphoma, and plasmacytoid small lymphocytic lymphoma.
director of the Leukemia/Lymphoma Program at the University of Michigan Comprehensive Cancer Center, on 14 small lymphocytic lymphoma (SLL) patients treated with Bexxar in four Phase I-III clinical trials.
is indicated for the treatment of relapsed follicular B-Cell non-Hodgkin lymphoma (FL), small lymphocytic lymphoma, and in combination with rituximab for patients with relapsed chronic lymphocytic leukemia (CLL).
Specific NHL diagnoses included are: small lymphocytic lymphoma or follicular lymphoma (small cleaved, mixed or large cell) as classified by the International Working Formulation Classification; or small lymphocytic, lymphoplasmacytoid, marginal, or follicular lymphoma as categorized by the Revised European-American Lymphoma (REAL) classification of the International Lymphoma Study Group (ILSG).
Food and Drug Administration (FDA) approval of idelalisib to treat patients with relapsed chronic lymphocytic leukemia (CLL), follicular lymphoma (FL) and small lymphocytic lymphoma (SLL) is a significant advance for patients with these blood cancers.
ABT-199 (GDC-0199) in Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL): High Complete Response Rate and Durable Disease Control; J.

Full browser ?